AAAAAA

   
Results: 1-10 |
Results: 10
Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
Authors: Gururangan, S Cokgor, I Rich, JN Edwards, S Affronti, ML Quinn, JA Herndon, JE Provenzale, JM McLendon, RE Tourt-Uhlig, S Sampson, JH Stafford-Fox, V Zaknoen, S Early, M Friedman, AH Friedman, HS
Citation: S. Gururangan et al., Phase I study of Gliadel (TM) wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas, NEURO-ONCOL, 3(4), 2001, pp. 246-250
Biological principles of brain tumor immunotherapy
Authors: Heimberger, AB Bigner, DD Sampson, JH
Citation: Ab. Heimberger et al., Biological principles of brain tumor immunotherapy, BRAIN TUMOR IMMUNOTHERAPY, 2001, pp. 101-130
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats
Authors: Heimberger, AB Archer, GE McLendon, RE Hulette, C Friedman, AH Friedman, HS Bigner, DD Sampson, JH
Citation: Ab. Heimberger et al., Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats, CLIN CANC R, 6(10), 2000, pp. 4148-4153
Ethnomedicinally selected plants as sources of potential analgesic compounds: Indication of in vitro biological activity in receptor binding assays
Authors: Sampson, JH Phillipson, JD Bowery, NG O'Neill, MJ Houston, JG Lewis, JA
Citation: Jh. Sampson et al., Ethnomedicinally selected plants as sources of potential analgesic compounds: Indication of in vitro biological activity in receptor binding assays, PHYTOTHER R, 14(1), 2000, pp. 24-29
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
Authors: Heimberger, AB Crotty, LE Archer, GE McLendon, RE Friedman, A Dranoff, G Bigner, DD Sampson, JH
Citation: Ab. Heimberger et al., Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma, J NEUROIMM, 103(1), 2000, pp. 16-25
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
Authors: Sampson, JH Crotty, LE Lee, S Archer, GE Ashley, DM Wikstrandt, CJ Hale, LP Small, C Dranoff, G Friedman, AH Friedman, HS Bigner, DD
Citation: Jh. Sampson et al., Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors, P NAS US, 97(13), 2000, pp. 7503-7508
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1
Authors: Archer, GE Sampson, JH Lorimer, IAJ McLendon, RE Kuan, CT Friedman, AH Friedman, HS Pastan, IH Bigner, DD
Citation: Ge. Archer et al., Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1, CLIN CANC R, 5(9), 1999, pp. 2646-2652
Treatment of neoplastic meningitis with intrathecal temozolomide
Authors: Sampson, JH Archer, GE Villavicencio, AT McLendon, RE Friedman, AH Bishop, WR Bigner, DD Friedman, HS
Citation: Jh. Sampson et al., Treatment of neoplastic meningitis with intrathecal temozolomide, CLIN CANC R, 5(5), 1999, pp. 1183-1188
Monoclonal antibody therapy of human gliomas: Current status and future approaches
Authors: Wikstrand, CJ Cokgor, I Sampson, JH Bigner, DD
Citation: Cj. Wikstrand et al., Monoclonal antibody therapy of human gliomas: Current status and future approaches, CANC METAST, 18(4), 1999, pp. 451-464
Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats
Authors: Archer, GE Sampson, JH McLendon, RE Friedman, AH Colvin, OM Rose, M Sands, H McCullough, W Fuchs, HE Bigner, DD Friedman, HS
Citation: Ge. Archer et al., Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats, J NEURO-ONC, 44(3), 1999, pp. 233-241
Risultati: 1-10 |